Traitement de l’alopécie areata : où en sommes-nous à la fin de 2020?
Traitement de l’alopécie areata : où en sommes-nous à la fin de 2020? Anthony Gilding, Communication de la science
Treating Alopecia Areata: Where are we at the end of 2020?
Treating Alopecia Areata: Where are we at the end of 2020? Anthony Gilding, Science and Research Communication at CANAAF
Introducing… Coffee and Conversation for Southwestern Ontario
We are excited to announce that we have expanded our Toronto Coffee and Conversation to include members from across Southwestern
Long Term use of JAK Inhibitors (CTP-543) Shows Promising Results In CoNCERT Pharmaceuticals Study
Long Term use of JAK Inhibitors (CTP-543) Shows Promising Results In CoNCERT Pharmaceuticals Study Anthony Gilding, Science Communication at
What you Missed: CANAAF Halloween Party
This past Saturday we held our Spook-tacular Halloween Party where we had everyone from witches to BB8 and Minnie Mouse
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study
Alopecia Areata is a particularly distressing condition. The hair loss faced by patients is unexpected, and often rapid, leaving them